BRIEF-Radius Health says FDA approves co's TYMLOS
* FDA approves Radius Health’s TYMLOS™ (abaloparatide), a bone building agent for the treatment of postmenopausal women with osteoporosis at high risk for fracture
Feb 16 Shanghai Kindly Enterprise Development Group Co Ltd:
* Says its Shanghai-based medical apparatus and instruments subsidiary was recognized as high-tech enterprise
* Says the subsidiary will enjoy a tax preference of 15 percent for three years
Source text in Chinese: goo.gl/gN7Upf
Further company coverage: (Beijing Headline News)
WASHINGTON, April 28 The U.S. House of Representatives on Friday overwhelmingly passed stopgap legislation to avert a government shutdown at midnight and give lawmakers another week to reach a deal on federal spending through the end of the fiscal year.